The C.D.C. made a statement in support of PrEP (pre-exposure prophylaxis in the form of the pill Truvada) on Wednesday. The institute recommends PrEP for people "at substantial risk for HIV," including men who have sex with men without condoms, HIV negative people in serodiscordant couples, and intravenous drug users.